Informa (LON:INF) Now Covered by Analysts at JPMorgan Chase & Co.

Research analysts at JPMorgan Chase & Co. initiated coverage on shares of Informa (LON:INFGet Free Report) in a research report issued on Tuesday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a GBX 1,020 ($13.52) price target on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 17.13% from the company’s previous close.

Separately, Shore Capital reissued a “buy” rating and issued a GBX 930 ($12.33) price target on shares of Informa in a research report on Friday, May 23rd.

Check Out Our Latest Research Report on Informa

Informa Stock Performance

Shares of INF stock opened at GBX 870.80 ($11.55) on Tuesday. The company has a quick ratio of 1.70, a current ratio of 0.56 and a debt-to-equity ratio of 31.98. Informa has a 52 week low of GBX 634.20 ($8.41) and a 52 week high of GBX 911.60 ($12.09). The stock has a market capitalization of £11.46 billion, a PE ratio of 37.50, a P/E/G ratio of 0.75 and a beta of 1.12. The firm has a 50 day moving average of GBX 814.57 and a two-hundred day moving average of GBX 798.02.

Informa (LON:INFGet Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported GBX 30.10 ($0.40) EPS for the quarter. Informa had a net margin of 9.30% and a return on equity of 4.75%. On average, research analysts predict that Informa will post 59.3240265 EPS for the current fiscal year.

Insider Activity

In related news, insider Stephen A. Carter sold 406,936 shares of the business’s stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of GBX 865 ($11.47), for a total transaction of £3,519,996.40 ($4,667,192.26). Company insiders own 0.53% of the company’s stock.

Informa Company Profile

(Get Free Report)

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

Featured Stories

Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.